Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Structure Therapeutics Inc. (GPCR)
USD53.45
+1.33 (+2.55%)
US NASDAQ Healthcare Biotechnology
Address
611 Gateway Boulevard 94080
South San Francisco, CA, US
South San Francisco, CA, US
CEO
Raymond C. Stevens
Website
structuretx.com
IPO
2023-02-03
CIK 1888886 ISIN US86366E1064
Description
Structure Therapeutics Inc., an international biopharmaceutical company currently in its clinical development phase, is committed to creating and providing groundbreaking oral therapies for various chronic diseases that lack adequate treatment options. The company's primary investigational drug, GSBR-1290, is an orally administered, biased small molecule agonist designed to target the glucagon-like-peptide-1 receptor (GLP-1R). This G-protein-coupled receptor (GPCR) is a recognized and validated therapeutic target for managing both type-2 diabetes mellitus and obesity. Furthermore, Structure Therapeutics is developing other oral small molecule treatments that act on different GPCRs, addressing pulmonary and cardiovascular conditions. For example, ANPA-0073 is a biased agonist aimed at the apelin receptor, a GPCR linked to diseases like idiopathic pulmonary fibrosis (IPF) and pulmonary arterial hypertension. Another compound in their pipeline is LTSE-2578, an oral small molecule that acts as a lysophosphatidic acid 1 receptor antagonist, also being explored for the treatment of IPF. Established in 2016, the company was formerly known as ShouTi Inc. and is headquartered in South San Francisco, California.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD53.45
+1.33 (+2.55%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
856.2K
Beta
-1.42
Float Shares
54.72M
Free Float %
95.1%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.25% | -6.84% | -30.58% | -47.47% | +5.35% | -45.59% | +53.70% | +43.33% | +45.54% | +45.54% | +45.54% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (14 ratings, all time)
Buy
Price Targets & DCF
Current price
53.45
Low
90.00
+68.4%
Consensus
114.75
+114.7%
Median
113.50
+112.3%
High
145.00
+171.3%
DCF (Unlevered)
13.17
-75.4%
DCF (Levered)
13.40
-74.9%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
94% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 4 | 0 |
| Buy | 12 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | 1 |
101.00
+89.0%
|
| Last Quarter | 2 |
123.00
+130.1%
|
| Last Year | 10 |
102.80
+92.3%
|
| All Time | 15 |
99.33
+85.8%
|
Quality scores
Altman Z-Score
21.90
Safe zone
Piotroski F-Score
2 / 9
Weak
MOAT Score
3 / 10
No MOAT
Composite Rating
C+
Overall Score
2 / 5
Medium
DCF Score
3 / 5
Medium
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
4 / 5
High
P/E Score
1 / 5
Low
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%—
-
EPS growth Biotechnology: +29.7%-2.6% Q1'26: -29.6% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%—
-
EBIT margin Biotechnology: +0.0%—
-
ROIC Biotechnology: -16.1%-183.5% Q1'26: +0.0% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+12.5% Q1'26: +26.3% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.05× Q1'26: -0.02× (vs Q1'25)
Valuation Multiples
From
To
Consensus Estimates
| Metric |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 8 Rev. Ana. 10 EPS Ana. |
Dec 2027 11 Rev. Ana. 9 EPS Ana. |
Dec 2028 8 Rev. Ana. 7 EPS Ana. |
Dec 2029 7 Rev. Ana. 2 EPS Ana. |
Dec 2030 7 Rev. Ana. 5 EPS Ana. |
|---|---|---|---|---|---|---|---|
| Revenue |
—
|
—
est: 21.35M (-100.0%)
|
31.25M
31.25M – 31.25M
+46.4% YoY
|
38.5K
38.5K – 38.5K
-99.9% YoY
|
186.40M
186.40M – 186.40M
+484,542.5% YoY
|
539.38M
539.38M – 539.38M
+189.4% YoY
|
831.55M
831.55M – 831.55M
+54.2% YoY
|
| EBITDA |
-157.24M
|
-136.79M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| EBIT |
-158.23M
|
-140.69M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| Net Income |
-122.53M
est: -46.08M (-165.9%)
|
-141.20M
est: -63.26M (-123.2%)
|
-28.14M
-125.54M – 69.26M
+55.5% YoY
|
-111.00M
-147.78M – -74.22M
-294.5% YoY
|
-87.13M
-111.43M – -62.82M
+21.5% YoY
|
-21.21M
-21.21M – -21.21M
+75.7% YoY
|
60.03M
60.03M – 60.03M
+383.0% YoY
|
| SGA |
49.41M
|
61.55M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| EPS |
-2.34
est: -0.81 (-188.5%)
|
-2.40
est: -1.06 (-126.3%)
|
-1.42
-2.12 – 1.17
-34.0% YoY
|
-1.98
-2.50 – -1.25
-39.3% YoY
|
-1.59
-1.88 – -1.06
+19.5% YoY
|
-0.36
-0.36 – -0.36
+77.5% YoY
|
1.01
1.01 – 1.01
+383.0% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-07 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 | 1/5 | 3/5 |
| 2026-05-06 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 | 1/5 | 3/5 |
| 2026-05-05 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-04 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-01 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-30 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-29 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-28 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-27 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-24 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-23 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-22 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-21 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-20 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-17 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-16 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-15 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
Owner Earnings
Owner's Earnings (history)
Owner's Earnings history not available.
Owner alignment
Owner's Earnings TTM
—
OE per share TTM
—
Owner's Yield
—
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
—
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
38
Total invested
163.15M
Insider transactions (90d)
0
Beneficial owners (>5%)
12
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Group Holdings LLP | 13.12M | 9.43% | — | 12.27M | — | — | HC | Delaware | 2024-02-08 | ↗ |
| 2 | Wellington Investment Advisors Holdings LLP | 13.12M | 9.43% | — | 12.27M | — | — | HC | Delaware | 2024-02-08 | ↗ |
| 3 | Wellington Management Group LLP | 13.12M | 9.43% | — | 12.27M | — | — | HC | Massachusetts | 2024-02-08 | ↗ |
| 4 | Wellington Management Company LLP | 12.87M | 9.25% | — | 12.21M | — | — | IA | Delaware | 2024-02-08 | ↗ |
| 5 | David Kroin | 7.94M | 7.61% | — | 7.94M | — | — | HC, IN | United States | 2023-02-03 | ↗ |
| 6 | Deep Track Biotechnology Master Fund, Ltd. | 7.94M | 7.61% | — | 7.94M | — | — | CO | Cayman Islands | 2023-02-03 | ↗ |
| 7 | Deep Track Capital, LP | 7.94M | 7.61% | — | 7.94M | — | — | IA, OO | Delaware | 2023-02-03 | ↗ |
| 8 | s | 7.23M | 5.20% | — | 7.23M | — | — | HC, IN | Delaware | 2024-05-30 | ↗ |
| 9 | Avoro Capital Advisors LLC | 7.00M | 5.00% | 7.00M | — | 7.00M | — | IA, OO | Delaware | 2024-02-14 | ↗ |
| 10 | Behzad Aghazadeh | 7.00M | 5.00% | 7.00M | — | 7.00M | — | IN | United States | 2024-02-14 | ↗ |
| 11 | EIN #00-0000000 | 3.96M | 6.90% | — | 3.96M | — | 3.96M | IA, HC | Jersey, Channel Islands | 2024-11-14 | ↗ |
| 12 | 95-1411037 | 13.00 | 6.20% | 10.59M | — | 10.59M | — | IA | Delaware | 2024-11-12 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
38
-172 vs prev Q
New positions
8
Closed positions
169
Increased
23
Reduced
7
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | MACQUARIE MANAGEMENT HOLDINGS, INC. | 82.6K +82.6K (+100.0%) | 5.75B +5.7B (+100.0%) | 0.14% +0.141 pp | 0.01% +0.009 pp | USD69.55 +0.0% | 1 qtrs NEW |
| 2 | — | 50.0K +50.0K (+100.0%) | 3.48B +3.5B (+100.0%) | 0.09% +0.086 pp | 1.93% +1.928 pp | USD69.55 +0.0% | 1 qtrs NEW |
| 3 | FMR LLC | 8.71M +3.5M (+65.9%) | 605.94M +458.9M (+312.2%) | 14.90% +5.919 pp | 0.03% +0.023 pp | USD50.44 +37.9% | 12 qtrs — |
| 4 | WELLINGTON MANAGEMENT GROUP LLP | 7.12M +1.4M (+25.2%) | 495.33M +336.0M (+210.9%) | 12.18% +2.450 pp | 0.09% +0.059 pp | USD46.96 +48.1% | 12 qtrs — |
| 5 | AVORO CAPITAL ADVISORS LLC | 6.56M +1.4M (+27.2%) | 455.94M +311.6M (+215.8%) | 11.21% +2.394 pp | 4.48% +2.615 pp | USD36.87 +88.6% | 2 qtrs — |
| 6 | JANUS HENDERSON GROUP PLC | 5.09M +641.3K (+14.4%) | 354.01M +229.4M (+184.1%) | 8.70% +1.097 pp | 0.16% +0.102 pp | USD44.90 +54.9% | 12 qtrs — |
| 7 | DEEP TRACK CAPITAL, LP | 4.11M -104.0K (-2.5%) | 285.97M +167.9M (+142.3%) | 7.03% -0.178 pp | 5.10% +1.805 pp | USD26.49 +162.6% | 12 qtrs — |
| 8 | BVF INC/IL | 3.48M +275.1K (+8.6%) | 241.97M +152.3M (+169.7%) | 5.95% +0.470 pp | 8.15% +4.509 pp | USD34.70 +100.4% | 12 qtrs — |
| 9 | MORGAN STANLEY | 2.09M +1.5M (+261.4%) | 145.21M +129.0M (+797.6%) | 3.57% +2.582 pp | 0.01% +0.008 pp | USD57.20 +21.6% | 12 qtrs — |
| 10 | PRICE T ROWE ASSOCIATES INC /MD/ | 1.67M +1.4M (+477.5%) | 116.23M +108.1M (+1,334.2%) | 2.86% +2.362 pp | 0.01% +0.012 pp | USD64.27 +8.2% | 12 qtrs — |
| 11 | DRIEHAUS CAPITAL MANAGEMENT LLC | 1.64M +768.9K (+88.0%) | 114.23M +89.8M (+367.1%) | 2.81% +1.315 pp | 0.78% +0.601 pp | USD52.11 +33.5% | 12 qtrs — |
| 12 | BAKER BROS. ADVISORS LP | 1.43M -123.6K (-7.9%) | 99.63M +56.1M (+128.7%) | 2.45% -0.211 pp | 0.58% +0.269 pp | USD22.23 +212.9% | 6 qtrs — |
| 13 | PRINCIPAL FINANCIAL GROUP INC | 1.28M +496.7K (+63.1%) | 89.32M +67.3M (+305.1%) | 2.20% +0.849 pp | 0.05% +0.035 pp | USD48.93 +42.1% | 7 qtrs — |
| 14 | CASDIN CAPITAL, LLC | 1.18M -380.0K (-24.4%) | 81.72M +38.2M (+87.7%) | 2.01% -0.650 pp | 5.08% +1.446 pp | USD28.25 +146.2% | 12 qtrs — |
| 15 | ORBIMED ADVISORS LLC | 1.16M +22.5K (+2.0%) | 80.80M +48.9M (+153.3%) | 1.99% +0.039 pp | 1.66% +0.904 pp | USD29.95 +132.2% | 7 qtrs — |
| 16 | SIREN, L.L.C. | 1.08M +51.9K (+5.1%) | 75.02M +46.3M (+160.9%) | 1.84% +0.089 pp | 2.24% +1.113 pp | USD30.00 +131.8% | 2 qtrs — |
| 17 | TCG CROSSOVER MANAGEMENT, LLC | 920.9K -142.1K (-13.4%) | 64.05M +34.3M (+115.2%) | 1.57% -0.243 pp | 2.12% +0.655 pp | USD43.45 +60.1% | 12 qtrs — |
| 18 | CAPITOLIS LIQUID GLOBAL MARKETS LLC | 878.3K +878.3K (+100.0%) | 61.09M +61.1M (+100.0%) | 1.50% +1.502 pp | 0.36% +0.364 pp | USD69.55 +0.0% | 1 qtrs NEW |
| 19 | FRANKLIN RESOURCES INC | 870.6K +124.8K (+16.7%) | 60.55M +39.7M (+190.0%) | 1.49% +0.214 pp | 0.01% +0.010 pp | USD39.53 +75.9% | 12 qtrs — |
| 20 | ALLIANCEBERNSTEIN L.P. | 848.9K +819.3K (+2,771.7%) | 59.04M +58.2M (+7,033.1%) | 1.45% +1.401 pp | 0.02% +0.018 pp | USD67.91 +2.4% | 7 qtrs — |
| 21 | DEUTSCHE BANK AG\ | 841.2K +841.2K (+100.0%) | 58.50M +58.5M (+100.0%) | 1.44% +1.438 pp | 0.02% +0.019 pp | USD69.55 +0.0% | 1 qtrs NEW |
| 22 | CITADEL ADVISORS LLC | 772.5K +328.7K (+74.1%) | 53.73M +41.3M (+332.4%) | 1.32% +0.562 pp | 0.01% +0.006 pp | USD50.33 +38.2% | 12 qtrs — |
| 23 | DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 768.0K +394.6K (+105.7%) | 53.41M +43.0M (+410.9%) | 1.31% +0.675 pp | 0.68% +0.523 pp | USD52.67 +32.0% | 12 qtrs — |
| 24 | ROCK SPRINGS CAPITAL MANAGEMENT LP | 748.2K -202.9K (-21.3%) | 52.04M +25.4M (+95.4%) | 1.28% -0.347 pp | 2.67% +1.112 pp | USD39.23 +77.3% | 9 qtrs — |
| 25 | PACIFIC HEIGHTS ASSET MANAGEMENT LLC | 700.0K +— (+0.0%) | 48.69M +29.1M (+148.4%) | 1.20% +0.000 pp | 1.82% +0.956 pp | USD23.23 +199.4% | 3 qtrs — |
| 26 | LOGOS GLOBAL MANAGEMENT LP | 600.0K -250.0K (-29.4%) | 41.73M +17.9M (+75.3%) | 1.03% -0.427 pp | 2.52% +0.388 pp | USD29.49 +135.8% | 12 qtrs — |
| 27 | AMERICAN CENTURY COMPANIES INC | 507.0K +20.2K (+4.1%) | 35.26M +21.6M (+158.7%) | 0.87% +0.035 pp | 0.02% +0.011 pp | USD40.86 +70.2% | 8 qtrs — |
| 28 | HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 467.8K +467.8K (+100.0%) | 32.54M +32.5M (+100.0%) | 0.80% +0.800 pp | 0.05% +0.054 pp | USD69.55 +0.0% | 1 qtrs NEW |
| 29 | FARALLON CAPITAL MANAGEMENT LLC | 454.0K +454.0K (+100.0%) | 31.58M +31.6M (+100.0%) | 0.78% +0.776 pp | 0.15% +0.149 pp | USD69.55 +0.0% | 1 qtrs NEW |
| 30 | BLACKROCK, INC. | 430.1K +166.1K (+62.9%) | 29.91M +22.5M (+304.8%) | 0.74% +0.284 pp | 0.00% +0.000 pp | USD53.04 +31.1% | 6 qtrs — |
| 31 | SC CHINA HOLDING LTD | 266.1K +— (+0.0%) | 24.44M +19.8M (+430.4%) | 0.45% +0.000 pp | 1.29% +1.052 pp | USD50.42 +37.9% | 10 qtrs — |
| 32 | STEMPOINT CAPITAL LP | 351.1K +221.7K (+171.4%) | 24.42M +20.8M (+574.2%) | 0.60% +0.379 pp | 4.19% +3.461 pp | USD54.24 +28.2% | 2 qtrs — |
| 33 | ECOR1 CAPITAL, LLC | 334.4K +334.4K (+100.0%) | 23.26M +23.3M (+100.0%) | 0.57% +0.572 pp | 1.06% +1.055 pp | USD69.55 +0.0% | 1 qtrs NEW |
| 34 | AMERIPRISE FINANCIAL INC | 285.5K -938.6K (-76.7%) | 19.86M -14.4M (-42.1%) | 0.49% -1.605 pp | 0.00% -0.003 pp | USD36.95 +88.2% | 9 qtrs — |
| 35 | ARROWMARK COLORADO HOLDINGS LLC | 271.2K -52.0K (-16.1%) | 18.86M +9.8M (+108.5%) | 0.46% -0.089 pp | 0.42% +0.247 pp | USD33.39 +108.3% | 12 qtrs — |
| 36 | NATIONAL BANK OF CANADA /FI/ | 265.4K +121.4K (+84.3%) | 18.46M +14.4M (+357.8%) | 0.45% +0.208 pp | 0.02% +0.013 pp | USD47.00 +48.0% | 6 qtrs — |
| 37 | ABRDN PLC | 264.9K -322.0K (-54.9%) | 18.42M +2.0M (+12.1%) | 0.45% -0.551 pp | 0.03% +0.003 pp | USD28.85 +141.1% | 7 qtrs — |
| 38 | CATALIO CAPITAL MANAGEMENT, LP | 252.9K -398.9K (-61.2%) | 17.59M -661.4K (-3.6%) | 0.43% -0.682 pp | 3.11% -0.265 pp | USD25.23 +175.7% | 5 qtrs — |
| 39 | CAPRICORN FUND MANAGERS LTD | 252.6K +252.6K (+100.0%) | 17.57M +17.6M (+100.0%) | 0.43% +0.432 pp | 4.23% +4.235 pp | USD69.55 +0.0% | 1 qtrs NEW |
| 40 | VOLORIDGE INVESTMENT MANAGEMENT, LLC | 250.0K +250.0K (+100.0%) | 17.39M +17.4M (+100.0%) | 0.43% +0.427 pp | 0.06% +0.061 pp | USD69.55 +0.0% | 1 qtrs NEW |
| 41 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 236.1K -800.0 (-0.3%) | 16.42M +9.8M (+147.6%) | 0.40% -0.001 pp | 0.00% +0.001 pp | USD28.73 +142.1% | 9 qtrs — |
| 42 | MONASHEE INVESTMENT MANAGEMENT LLC | 225.0K +25.0K (+12.5%) | 15.65M +10.0M (+179.4%) | 0.38% +0.043 pp | 8.82% +6.026 pp | USD30.95 +124.7% | 12 qtrs — |
| 43 | GOLDMAN SACHS GROUP INC | 224.3K -280.1K (-55.5%) | 15.60M +1.5M (+10.5%) | 0.38% -0.479 pp | 0.00% +0.000 pp | USD33.94 +104.9% | 10 qtrs — |
| 44 | BALYASNY ASSET MANAGEMENT L.P. | 216.2K -245.4K (-53.2%) | 15.04M +2.1M (+16.4%) | 0.37% -0.420 pp | 0.02% +0.003 pp | USD28.00 +148.4% | 4 qtrs — |
| 45 | UBS GROUP AG | 202.5K -5.6K (-2.7%) | 14.08M +8.3M (+141.7%) | 0.35% -0.010 pp | 0.00% +0.001 pp | USD29.28 +137.5% | 11 qtrs — |
| 46 | SIO CAPITAL MANAGEMENT, LLC | 201.5K +201.5K (+100.0%) | 14.01M +14.0M (+100.0%) | 0.34% +0.345 pp | 2.20% +2.204 pp | USD69.55 +0.0% | 1 qtrs NEW |
| 47 | HIGHVISTA STRATEGIES LLC | 193.0K -43.2K (-18.3%) | 13.42M +6.8M (+102.9%) | 0.33% -0.074 pp | 3.46% +1.836 pp | USD27.54 +152.5% | 10 qtrs — |
| 48 | DIADEMA PARTNERS LP | 191.7K +191.7K (+100.0%) | 13.33M +13.3M (+100.0%) | 0.33% +0.328 pp | 2.30% +2.297 pp | USD69.55 +0.0% | 1 qtrs NEW |
| 49 | TD ASSET MANAGEMENT INC | 174.7K +138.6K (+384.0%) | 12.15M +11.1M (+1,102.3%) | 0.30% +0.237 pp | 0.01% +0.009 pp | USD63.72 +9.1% | 12 qtrs — |
| 50 | MARSHALL WACE, LLP | 168.6K +168.6K (+100.0%) | 11.73M +11.7M (+100.0%) | 0.29% +0.288 pp | 0.01% +0.011 pp | USD69.55 +0.0% | 10 qtrs — |
| 51 | MILLENNIUM MANAGEMENT LLC | 152.6K -1.1M (-88.0%) | 10.61M -25.1M (-70.3%) | 0.26% -1.918 pp | 0.00% -0.011 pp | USD32.39 +114.7% | 12 qtrs — |
| 52 | RHENMAN & PARTNERS ASSET MANAGEMENT AB | 147.6K -32.5K (-18.0%) | 10.27M +5.2M (+103.6%) | 0.25% -0.056 pp | 0.96% +0.401 pp | USD21.22 +227.8% | 4 qtrs — |
| 53 | JANE STREET GROUP, LLC | 147.2K +147.2K (+100.0%) | 10.24M +10.2M (+100.0%) | 0.25% +0.252 pp | 0.00% +0.002 pp | USD69.55 +0.0% | 1 qtrs NEW |
| 54 | BELLEVUE GROUP AG | 145.2K -170.7K (-54.0%) | 10.10M +1.3M (+14.2%) | 0.25% -0.292 pp | 0.19% +0.008 pp | USD33.73 +106.2% | 10 qtrs — |
| 55 | EVERSEPT PARTNERS, LP | 127.6K -38.8K (-23.3%) | 8.87M +4.2M (+90.4%) | 0.22% -0.066 pp | 0.45% +0.126 pp | USD23.67 +193.8% | 3 qtrs — |
| 56 | WOODLINE PARTNERS LP | 123.9K +58.5K (+89.3%) | 8.62M +6.8M (+370.3%) | 0.21% +0.100 pp | 0.03% +0.025 pp | USD49.59 +40.3% | 12 qtrs — |
| 57 | RENAISSANCE TECHNOLOGIES LLC | 115.2K -38.7K (-25.1%) | 8.01M +3.7M (+85.9%) | 0.20% -0.066 pp | 0.01% +0.007 pp | USD22.37 +210.9% | 4 qtrs — |
| 58 | ALYESKA INVESTMENT GROUP, L.P. | 115.0K -129.8K (-53.0%) | 8.00M +1.1M (+16.7%) | 0.20% -0.222 pp | 0.02% +0.002 pp | USD28.00 +148.4% | 2 qtrs — |
| 59 | JEFFERIES FINANCIAL GROUP INC. | 103.0K -67.4K (-39.5%) | 7.16M +2.4M (+50.2%) | 0.18% -0.115 pp | 0.04% +0.014 pp | USD28.00 +148.4% | 2 qtrs — |
| 60 | RTW INVESTMENTS, LP | 100.0K +100.0K (+100.0%) | 6.96M +7.0M (+100.0%) | 0.17% +0.171 pp | 0.07% +0.070 pp | USD69.55 +0.0% | 1 qtrs NEW |
| 61 | JAIN GLOBAL LLC | 100.0K +100.0K (+100.0%) | 6.95M +7.0M (+100.0%) | 0.17% +0.171 pp | 0.03% +0.034 pp | USD69.55 +0.0% | 4 qtrs — |
| 62 | SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 99.6K +— (+0.0%) | 6.93M +4.1M (+148.4%) | 0.17% +0.000 pp | 0.24% +0.127 pp | USD17.31 +301.8% | 4 qtrs — |
| 63 | TWO SIGMA INVESTMENTS, LP | 95.5K -87.4K (-47.8%) | 6.65M +1.5M (+29.7%) | 0.16% -0.149 pp | 0.01% +0.002 pp | USD28.00 +148.4% | 2 qtrs — |
| 64 | SUMMITTX CAPITAL, L.P. | 94.7K +94.7K (+100.0%) | 6.58M +6.6M (+100.0%) | 0.16% +0.162 pp | 0.20% +0.198 pp | USD69.55 +0.0% | 1 qtrs NEW |
| 65 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | 96.4K +67.9K (+237.8%) | 6.53M +5.7M (+717.8%) | 0.16% +0.116 pp | 0.01% +0.005 pp | USD61.47 +13.1% | 11 qtrs — |
| 66 | SIMPLEX TRADING, LLC | 92.7K +67.5K (+268.3%) | 6.45M +5.7M (+815.5%) | 0.16% +0.115 pp | 0.00% +0.003 pp | USD60.04 +15.8% | 9 qtrs — |
| 67 | SOLEUS CAPITAL MANAGEMENT, L.P. | 90.0K +90.0K (+100.0%) | 6.26M +6.3M (+100.0%) | 0.15% +0.154 pp | 0.23% +0.231 pp | USD69.55 +0.0% | 1 qtrs NEW |
| 68 | B GROUP, INC. | 90.0K +90.0K (+100.0%) | 6.26M +6.3M (+100.0%) | 0.15% +0.154 pp | 4.62% +4.622 pp | USD69.55 +0.0% | 1 qtrs NEW |
| 69 | BIRCHVIEW CAPITAL, LP | 90.0K +12.0K (+15.4%) | 6.26M +4.1M (+186.6%) | 0.15% +0.021 pp | 3.66% +2.016 pp | USD30.64 +127.0% | 3 qtrs — |
| 70 | TREXQUANT INVESTMENT LP | 89.9K +69.8K (+345.4%) | 6.26M +5.7M (+1,006.5%) | 0.15% +0.119 pp | 0.06% +0.050 pp | USD58.98 +17.9% | 8 qtrs — |
| 71 | PLATINUM INVESTMENT MANAGEMENT LTD | 87.9K -34.9K (-28.4%) | 6.11M +2.7M (+77.8%) | 0.15% -0.060 pp | 1.41% +1.190 pp | USD34.47 +101.8% | 12 qtrs — |
| 72 | BREVAN HOWARD CAPITAL MANAGEMENT LP | 86.3K +86.3K (+100.0%) | 5.96M +6.0M (+100.0%) | 0.15% +0.148 pp | 0.07% +0.065 pp | USD69.55 +0.0% | 1 qtrs NEW |
| 73 | PEREGRINE CAPITAL MANAGEMENT LLC | 84.3K +84.3K (+100.0%) | 5.86M +5.9M (+100.0%) | 0.14% +0.144 pp | 0.18% +0.180 pp | USD69.55 +0.0% | 1 qtrs NEW |
| 74 | UNIVERSAL- BETEILIGUNGS- UND SERVICEGESELLSCHAFT MBH | 83.1K +67.3K (+428.5%) | 5.78M +5.3M (+1,212.8%) | 0.14% +0.115 pp | 0.01% +0.009 pp | USD61.56 +13.0% | 5 qtrs — |
| 75 | VERITION FUND MANAGEMENT LLC | 78.1K +38.8K (+98.6%) | 5.44M +4.3M (+393.3%) | 0.13% +0.066 pp | 0.02% +0.017 pp | USD44.51 +56.3% | 7 qtrs — |
| 76 | BOXER CAPITAL MANAGEMENT, LLC | 75.0K +75.0K (+100.0%) | 5.22M +5.2M (+100.0%) | 0.13% +0.128 pp | 1.14% +1.142 pp | USD69.55 +0.0% | 1 qtrs NEW |
| 77 | WALLEYE TRADING LLC | 70.2K -43.4K (-38.2%) | 4.88M +1.7M (+53.5%) | 0.12% -0.074 pp | 0.01% +0.002 pp | USD19.86 +250.2% | 4 qtrs — |
| 78 | PFM HEALTH SCIENCES, LP | 68.2K -46.8K (-40.7%) | 4.75M +1.5M (+47.3%) | 0.12% -0.080 pp | 0.47% +0.226 pp | USD23.23 +199.4% | 4 qtrs — |
| 79 | SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 68.1K +12.1K (+21.7%) | 4.74M +3.2M (+202.3%) | 0.12% +0.021 pp | 0.07% +0.048 pp | USD31.15 +123.3% | 3 qtrs — |
| 80 | LONGAEVA PARTNERS L.P. | 60.0K +60.0K (+100.0%) | 4.17M +4.2M (+100.0%) | 0.10% +0.103 pp | 0.35% +0.350 pp | USD69.55 +0.0% | 1 qtrs NEW |
| 81 | BURKEHILL GLOBAL MANAGEMENT, LP | 60.0K +60.0K (+100.0%) | 4.17M +4.2M (+100.0%) | 0.10% +0.103 pp | 0.27% +0.275 pp | USD69.55 +0.0% | 1 qtrs NEW |
| 82 | BANQUE PICTET & CIE SA | 59.9K -4.3K (-6.7%) | 4.16M +2.4M (+131.7%) | 0.10% -0.007 pp | 0.02% +0.014 pp | USD41.42 +67.9% | 6 qtrs — |
| 83 | ADVISOR GROUP HOLDINGS, INC. | 59.2K -3.6K (-5.7%) | 4.12M +2.9M (+235.6%) | 0.10% -0.006 pp | 0.01% +0.004 pp | USD23.95 +190.4% | 10 qtrs — |
| 84 | VOYA INVESTMENT MANAGEMENT LLC | 55.3K +38.9K (+236.7%) | 3.85M +3.4M (+736.3%) | 0.09% +0.067 pp | 0.00% +0.003 pp | USD59.89 +16.1% | 10 qtrs — |
| 85 | GEODE CAPITAL MANAGEMENT, LLC | 55.1K -2.8K (-4.8%) | 3.84M +2.2M (+136.3%) | 0.09% -0.005 pp | 0.00% +0.000 pp | USD36.82 +88.9% | 11 qtrs — |
| 86 | PARKMAN HEALTHCARE PARTNERS LLC | 55.0K +55.0K (+100.0%) | 3.83M +3.8M (+100.0%) | 0.09% +0.094 pp | 0.36% +0.364 pp | USD69.55 +0.0% | 1 qtrs NEW |
| 87 | BANK OF MONTREAL /CAN/ | 54.3K -6.4K (-10.5%) | 3.68M +2.0M (+116.6%) | 0.09% -0.011 pp | 0.00% +0.001 pp | USD37.26 +86.7% | 7 qtrs — |
| 88 | INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 50.0K +50.0K (+100.0%) | 3.48M +3.5M (+100.0%) | 0.09% +0.086 pp | 0.17% +0.173 pp | USD69.55 +0.0% | 1 qtrs NEW |
| 89 | SEVEN GRAND MANAGERS, LLC | 50.0K +50.0K (+100.0%) | 3.48M +3.5M (+100.0%) | 0.09% +0.086 pp | 0.26% +0.265 pp | USD69.55 +0.0% | 1 qtrs NEW |
| 90 | ALPS ADVISORS INC | 49.7K +21.8K (+77.9%) | 3.46M +2.7M (+341.8%) | 0.09% +0.037 pp | 0.02% +0.016 pp | USD45.69 +52.2% | 5 qtrs — |
| 91 | PIER CAPITAL, LLC | 48.8K -148.8K (-75.3%) | 3.39M -2.1M (-38.7%) | 0.08% -0.254 pp | 0.54% -0.323 pp | USD32.45 +114.3% | 9 qtrs — |
| 92 | STATE STREET CORP | 48.2K +2.2K (+4.8%) | 3.35M +2.1M (+160.3%) | 0.08% +0.004 pp | 0.00% +0.000 pp | USD29.82 +133.2% | 11 qtrs — |
| 93 | ANTIPODES PARTNERS LTD | 46.3K +42.2K (+1,035.1%) | 3.25M +3.1M (+2,742.9%) | 0.08% +0.072 pp | 0.07% +0.066 pp | USD65.46 +6.2% | 7 qtrs — |
| 94 | RAYMOND JAMES FINANCIAL INC | 44.4K +44.4K (+100.0%) | 3.09M +3.1M (+100.0%) | 0.08% +0.076 pp | 0.00% +0.001 pp | USD69.55 +0.0% | 3 qtrs — |
| 95 | MARINER, LLC | 44.2K +19.0 (+0.0%) | 3.07M +1.8M (+148.5%) | 0.08% +0.000 pp | 0.00% +0.002 pp | USD24.13 +188.2% | 5 qtrs — |
Ownership breakdown by holder
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Ratio by volume
0.00
Bearish
Buys
0
Sells
2
Shares acquired
—
Shares disposed
17.5K
Cash buys
—
Cash sales
2.00
Net activity
-17,452
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-15 | Lang Matthew | Officer | A-Award | A | Share option (right to buy) | 223,776 | 18.08 | 4.05M | 223,776 | D | ↗ |
| 2026-04-14 | FMR LLC | 10% Owner | S-Sale | D | American Depositary Shares | 16,085 | 0.00 | — | 32,171 | I | ↗ |
| 2026-03-19 | Yoon Jun | Officer | A-Award | A | Employee Stock Option (right to buy) | 128,892 | 16.82 | 2.17M | 128,892 | D | ↗ |
| 2026-03-19 | Stevens Raymond C | Director / Officer | A-Award | A | Employee Stock Option (right to buy) | 322,230 | 16.82 | 5.42M | 322,230 | D | ↗ |
| 2026-03-19 | Ma Yingli | Officer | A-Award | A | Ordinary Shares | 32,526 | 0.00 | — | 139,917 | D | ↗ |
| 2026-03-19 | Lin Xichen | Officer | A-Award | A | Ordinary Shares | 43,368 | 0.00 | — | 228,960 | D | ↗ |
| 2026-03-19 | Hall Ashley | Officer | A-Award | A | Employee Stock Option (right to buy) | 59,073 | 16.82 | 993.6K | 59,073 | D | ↗ |
| 2026-03-19 | Coll Crespo Blas | Officer | A-Award | A | Employee Stock Option (right to buy) | 93,984 | 16.82 | 1.58M | 93,984 | D | ↗ |
| 2026-03-03 | Yoon Jun | Officer | F-InKind | D | Ordinary Shares | 22,305 | 20.99 | 468.2K | 1,297,571 | D | ↗ |
| 2026-03-03 | Stevens Raymond C | Director / Officer | F-InKind | D | Ordinary Shares | 53,454 | 20.99 | 1.12M | 1,141,376 | D | ↗ |
| 2026-03-03 | Ma Yingli | Officer | F-InKind | D | Ordinary Shares | 11,313 | 20.99 | 237.5K | 107,391 | D | ↗ |
| 2026-03-03 | Lin Xichen | Officer | F-InKind | D | Ordinary Shares | 18,735 | 20.99 | 393.2K | 185,592 | D | ↗ |
| 2026-03-03 | Hall Ashley | Officer | F-InKind | D | Ordinary Shares | 4,836 | 20.99 | 101.5K | 107,481 | D | ↗ |
| 2026-03-03 | Coll Crespo Blas | Officer | F-InKind | D | Ordinary Shares | 11,826 | 20.99 | 248.2K | 204,981 | D | ↗ |
| 2026-01-15 | FMR LLC | 10% Owner | S-Sale | D | American Depositary Shares | 5,477 | 0.00 | — | 58,864 | I | ↗ |
| 2025-12-08 | FMR LLC | 10% Owner | S-Sale | D | American Depositary Shares | 15,535 | 0.00 | — | 0 | I | ↗ |
| 2025-11-20 | Stevens Raymond C | Director / Officer | A-Award | A | American Depositary Shares | 824 | 0.00 | — | 1,824 | D | ↗ |
| 2025-11-20 | Hall Ashley | Officer | A-Award | A | American Depositary Shares | 237 | 0.00 | — | 462 | D | ↗ |
| 2025-09-18 | Hall Ashley | Officer | F-InKind | D | Ordinary Shares | 6,021 | 7.74 | 46.6K | 112,317 | D | ↗ |
| 2025-09-18 | Coll Crespo Blas | Officer | F-InKind | D | Ordinary Shares | 8,106 | 7.74 | 62.8K | 216,807 | D | ↗ |
| 2025-07-30 | FMR LLC | 10% Owner | S-Sale | D | American Depositary Shares | 26,310 | 0.00 | — | 1,515,558 | I | ↗ |
| 2025-07-01 | Yoon Jun | Officer | F-InKind | D | Ordinary Shares | 7,089 | 6.84 | 48.5K | 1,319,876 | D | ↗ |
| 2025-07-01 | Stevens Raymond C | Director / Officer | F-InKind | D | Ordinary Shares | 16,050 | 6.84 | 109.7K | 1,194,830 | D | ↗ |
| 2025-07-01 | Ma Yingli | Officer | A-Award | A | Ordinary Shares | 24,459 | 0.00 | — | 123,174 | D | ↗ |
| 2025-07-01 | Lin Xichen | Officer | A-Award | A | Ordinary Shares | 57,078 | 0.00 | — | 217,173 | D | ↗ |
| 2025-07-01 | Coll Crespo Blas | Officer | F-InKind | D | Ordinary Shares | 1,434 | 6.84 | 9.8K | 224,913 | D | ↗ |
| 2025-06-23 | Waldstreicher Joanne | Director | A-Award | A | Share Option (right to buy) | 51,804 | 7.37 | 381.8K | 51,804 | D | ↗ |
| 2025-06-23 | WELCH DANIEL G | Director | A-Award | A | Share Option (right to buy) | 51,804 | 7.37 | 381.8K | 51,804 | D | ↗ |
| 2025-06-23 | TETLOW SHARON | Director | A-Award | A | Share Option (right to buy) | 51,804 | 7.37 | 381.8K | 51,804 | D | ↗ |
| 2025-06-23 | Russell Angus C. | Director | A-Award | A | Share Option (right to buy) | 42,833 | 7.37 | 315.7K | 42,833 | D | ↗ |
| 2025-06-23 | LOVE TED W | Director | A-Award | A | Share Option (right to buy) | 51,804 | 7.37 | 381.8K | 51,804 | D | ↗ |
| 2025-06-23 | DOBMEIER ERIC | Director | A-Award | A | Share Option (right to buy) | 51,804 | 7.37 | 381.8K | 51,804 | D | ↗ |
| 2025-05-21 | Yoon Jun | Officer | A-Award | A | American Depositary Shares | 831 | 0.00 | — | 2,946 | D | ↗ |
| 2025-05-21 | Stevens Raymond C | Director / Officer | A-Award | A | American Depositary Shares | 1,000 | 0.00 | — | 1,000 | D | ↗ |
| 2025-05-21 | Coll Crespo Blas | Officer | A-Award | A | American Depositary Shares | 429 | 0.00 | — | 1,157 | D | ↗ |
| 2025-05-20 | Hall Ashley | Officer | A-Award | A | American Depositary Shares | 225 | 0.00 | — | 225 | D | ↗ |
| 2025-03-15 | Yoon Jun | Officer | A-Award | A | Ordinary Shares | 170,166 | 0.00 | — | 1,293,299 | D | ↗ |
| 2025-03-15 | Stevens Raymond C | Director / Officer | A-Award | A | Ordinary Shares | 340,332 | 0.00 | — | 1,133,678 | D | ↗ |
| 2025-03-15 | Ma Yingli | Officer | A-Award | A | Employee Stock Option (right to buy) | 155,040 | 7.02 | 1.09M | 155,040 | D | ↗ |
| 2025-03-15 | Lin Xichen | Officer | A-Award | A | Employee Stock Option (right to buy) | 196,386 | 7.02 | 1.38M | 196,386 | D | ↗ |
| 2025-03-15 | Hall Ashley | Officer | A-Award | A | Employee Stock Option (right to buy) | 124,032 | 7.02 | 870.7K | 124,032 | D | ↗ |
| 2025-03-15 | Coll Crespo Blas | Officer | A-Award | A | Ordinary Shares | 116,988 | 0.00 | — | 219,588 | D | ↗ |
| 2025-03-01 | Yoon Jun | Officer | F-InKind | D | Ordinary Shares | 5,940 | 7.92 | 47.0K | 1,287,359 | D | ↗ |
| 2025-03-01 | Stevens Raymond C | Director / Officer | F-InKind | D | Ordinary Shares | 12,495 | 7.92 | 98.9K | 1,121,183 | D | ↗ |
| 2025-03-01 | Ma Yingli | Officer | F-InKind | D | Ordinary Shares | 1,824 | 7.92 | 14.4K | 98,715 | D | ↗ |
| 2025-03-01 | Lin Xichen | Officer | F-InKind | D | Ordinary Shares | 6,441 | 7.92 | 51.0K | 160,095 | D | ↗ |
| 2025-03-01 | Coll Crespo Blas | Officer | F-InKind | D | Ordinary Shares | 1,233 | 7.92 | 9.8K | 218,355 | D | ↗ |
| 2025-02-06 | FMR LLC | 10% Owner | S-Sale | D | American Depositary Shares | 41 | 0.00 | — | 0 | I | ↗ |
| 2024-11-20 | Yoon Jun | Officer | A-Award | A | American Depositary Shares | 821 | 0.00 | — | 2,115 | D | ↗ |
| 2024-11-20 | Coll Crespo Blas | Officer | A-Award | A | American Depositary Shares | 363 | 0.00 | — | 728 | D | ↗ |
| 2024-09-18 | Hall Ashley | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-09-18 | Coll Crespo Blas | Officer | — | — | Ordinary Shares | 0 | 0.00 | — | 12,000 | D | ↗ |
| 2024-08-26 | Russell Angus C. | Director | A-Award | A | Share option (right to buy) | 75,000 | 13.53 | 1.01M | 75,000 | — | ↗ |
| 2024-06-25 | Waldstreicher Joanne | Director | A-Award | A | Share Option (right to buy) | 37,500 | 13.32 | 499.5K | 37,500 | — | ↗ |
| 2024-06-25 | WELCH DANIEL G | Director | A-Award | A | Share Option (right to buy) | 37,500 | 13.32 | 499.5K | 37,500 | — | ↗ |
| 2024-06-25 | TETLOW SHARON | Director | A-Award | A | Share Option (right to buy) | 37,500 | 13.32 | 499.5K | 37,500 | — | ↗ |
| 2024-06-25 | LOVE TED W | Director | A-Award | A | Share Option (right to buy) | 33,595 | 13.32 | 447.5K | 33,595 | — | ↗ |
| 2024-06-25 | DOBMEIER ERIC | Director | A-Award | A | Share Option (right to buy) | 37,500 | 13.32 | 499.5K | 37,500 | — | ↗ |
| 2024-06-12 | Stevens Raymond C | Director / Officer | M-Exempt | D | Share Option (right to buy) | 50,001 | 0.48 | 24.0K | 488,766 | — | ↗ |
| 2024-06-10 | Stevens Raymond C | Director / Officer | C-Conversion | D | Ordinary Shares | 555,000 | 0.00 | — | 643,346 | — | ↗ |
| 2024-06-06 | FMR LLC | 10% Owner | — | I | Ordinary Shares | 0 | 0.00 | — | 530,814 | — | ↗ |
| 2024-06-03 | Lin Xichen | Officer | C-Conversion | A | American Depositary Shares | 35,400 | 0.00 | — | 35,400 | — | ↗ |
| 2024-05-20 | Yoon Jun | Officer | A-Award | A | American Depositary Shares | 694 | 0.00 | — | 1,294 | D | ↗ |
| 2024-04-17 | FMR LLC | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-03-15 | Yoon Jun | Officer | A-Award | A | Stock Option (right to buy) | 148,134 | 35.25 | 5.22M | 148,134 | — | ↗ |
| 2024-03-15 | Stevens Raymond C | Director / Officer | A-Award | A | Stock Option (right to buy) | 335,481 | 35.25 | 11.83M | 335,481 | — | ↗ |
| 2024-03-15 | Ma Yingli | Officer | A-Award | A | Ordinary Shares | 36,729 | 0.00 | — | 36,729 | — | ↗ |
| 2024-03-15 | Lin Xichen | Officer | A-Award | A | Ordinary Shares | 85,707 | 0.00 | — | 85,707 | — | ↗ |
| 2024-03-15 | Bach Mark Allen | Officer | A-Award | A | Ordinary Shares | 26,235 | 0.00 | — | 26,235 | — | ↗ |
| 2024-03-14 | FMR LLC | 10% Owner | S-Sale | D | American Depositary Shares | 21,997 | 0.00 | — | 1,541,868 | — | ↗ |
| 2024-02-13 | FMR LLC | 10% Owner | S-Sale | D | American Depositary Shares | 525 | 0.00 | — | 1,563,865 | — | ↗ |
| 2023-12-22 | FMR LLC | 10% Owner | J-Other | D | American Depositary Shares | 25,410 | 0.00 | — | 1,564,390 | — | ↗ |
| 2023-12-05 | FMR LLC | 10% Owner | S-Sale | D | American Depositary Shares | 16,086 | 0.00 | — | 32,169 | — | ↗ |
| 2023-10-18 | FMR LLC | 10% Owner | S-Sale | D | American Depositary Shares | 16,086 | 0.00 | — | 48,255 | — | ↗ |
| 2023-10-02 | FMR LLC | 10% Owner | — | I | Ordinary Shares | 0 | 0.00 | — | 723,837 | — | ↗ |
| 2023-08-03 | WELCH DANIEL G | Director | J-Other | D | Stock option (right to buy) | 411,000 | 2.60 | 1.07M | 768,122 | — | ↗ |
| 2023-08-03 | LOVE TED W | Director | A-Award | A | Stock option (right to buy) | 75,000 | 10.57 | 792.8K | 75,000 | — | ↗ |
| 2023-02-07 | Farid Ramy | Director | C-Conversion | A | Ordinary Shares | 642,245 | 0.00 | — | 3,260,495 | — | ↗ |
| 2023-02-07 | FMR LLC | Other | C-Conversion | A | Ordinary Shares | 6,947 | 0.00 | — | 82,035 | — | ↗ |
| 2023-02-02 | TETLOW SHARON | Director | — | D | Stock option (right to buy) | 80,000 | 2.79 | 223.2K | 0 | — | ↗ |
| 2023-02-02 | Farid Ramy | Director | — | I | Ordinary Shares | 0 | 0.00 | — | 2,618,250 | — | ↗ |
| 2023-02-02 | FMR LLC | 10% Owner | — | I | Series B-1 Convertible Preferred Shares | 214,663 | 0.00 | — | 0 | — | ↗ |
| 2023-02-02 | DOBMEIER ERIC | Director | — | D | Stock option (right to buy) | 80,000 | 3.36 | 268.8K | 0 | — | ↗ |
Executive team
Top executives
Shares Outstanding
57.57M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Raymond Stevens, Ph.D. Chief Executive Officer and Director | 672.1K | — | 2.39M | 4.85M | 508.9K | 14.0K | 8.43M | 85.82% | ↗ |
| 2 | 2025 | Jun Yoon Chief Financial Officer | 530.5K | — | 1.19M | 2.42M | 309.1K | 10.5K | 4.47M | 80.97% | ↗ |
| 3 | 2025 | Blai Coll, M.D., Ph.D. Chief Medical Officer | 492.8K | — | 820.9K | 1.67M | 253.2K | 14.0K | 3.25M | 76.59% | ↗ |
| 4 | 2025 | Xichen Lin, Ph.D. Chief Scientific Officer | 505.3K | — | 567.2K | 1.15M | 257.1K | — | 2.48M | 69.27% | ↗ |
| 5 | 2025 | Yingli Ma, Ph.D. Chief Technology Officer | 429.8K | — | 447.7K | 908.8K | 212.6K | — | 2.00M | 67.86% | ↗ |
| 6 | 2024 | Raymond Stevens, Ph.D. Chief Executive Officer and Director | 634.2K | — | 1.58M | 3.17M | 334.4K | 13.8K | 5.74M | 82.88% | ↗ |
| 7 | 2024 | Xichen Lin, Ph.D. Chief Scientific Officer | 476.5K | — | 1.01M | 2.02M | 185.8K | 1.7K | 3.69M | 82.01% | ↗ |
| 8 | 2024 | Blai Coll, M.D., Ph.D. Chief Medical Officer | 449.1K | — | 1.30M | 1.50M | 187.2K | 13.8K | 3.45M | 81.16% | ↗ |
| 9 | 2024 | Jun Yoon Chief Financial Officer | 482.3K | — | 698.8K | 1.40M | 217.1K | 13.8K | 2.81M | 74.65% | ↗ |
| 10 | 2023 | Raymond Stevens, Ph.D. Chief Executive Officer and Director | 595.9K | — | — | 6.50M | 281.3K | 13.2K | 7.39M | 87.95% | ↗ |
| 11 | 2023 | Jun Yoon Chief Financial Officer | 441.3K | — | — | 3.05M | 173.2K | 13.2K | 3.67M | 82.92% | ↗ |
| 12 | 2023 | Mark Bach, M.D., Ph.D. Chief Medical Officer | 485.8K | — | — | — | 173.0K | 13.2K | 672.1K | 0.00% | ↗ |
| 13 | 2022 | Raymond Stevens, Ph.D. Chief Executive Officer and Director | 487.3K | — | — | — | 247.5K | 12.5K | 747.3K | 0.00% | ↗ |
| 14 | 2022 | Mark Bach, M.D., Ph.D. Chief Medical Officer | 466.4K | — | — | — | 149.5K | 12.5K | 628.4K | 0.00% | ↗ |
CEO compensation breakdown
Proxy statements
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Raymond C. Stevens | Chief Executive Officer & Director | 1M | — |
| Jun S. Yoon | Co- Founder, Chief Financial Officer & Secretary | 850.1K | male |
| Xichen Lin | Chief Scientific Officer & GM of Structure Shanghai | 762.4K | — |
| Blai Coll | Chief Medical Officer | 760.0K | — |
| Yingli Ma | Chief Technology Officer | 642.4K | — |
| Lani Ibarra | Senior Vice President of Clinical Development Operations | — | female |
| Matthew Lang | COO & General Counsel | — | male |
| Hui Lei | Senior Vice President of Chemistry | — | — |
| Sam Lim | Senior Vice President of Cardiopulmonary Clinical Development | — | — |
| Tony Peng | Senior Vice President of Legal | — | male |
| Fang Zhang | Executive Vice President & Head of Biology | — | — |
| Xinglong Jiang | Senior Vice President of Preclinical Development | — | — |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
| Transaction Date | Disclosed | Senator | State | Owner | Type | Amount | Link |
|---|---|---|---|---|---|---|---|
| 2023-10-04 | 2023-11-02 | Thomas R. Carper | DE | Spouse | Sale (Full) | $1,001 - $15,000 | ↗ |
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for GPCR
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
